Dr. Robert Brueck MD, Fort Myers Florida plastic surgeon reports:
It is sort of like a heavy weight bout between two heavy weight fighters.
They take their gloves off and now it’s serious.
Botox maker Allergan has won a court injunction blocking Merz from selling their competing brand Xeomin. Apparently some Allergan employee’s came to work for Merz. So in the meantime while they “duke” it out, the roll-out of Xeomin will be blocked.
Round two to follow.
I don't think the difference between the results provided by Xeomin and botox is big but their popularity can't be compared.
ReplyDeleteWhile Xeomin tries to prove its effectiveness Botox is the no 1 anti aging treatment allover the word.
There's no wonder this miraculous product has no competition....only a treatment with a long lasting result could change things in the future.